Characterization of a selective inhibitor of the Parkinson’s disease kinase LRRK2


Mutations in leucine-rich repeat kinase 2 (LRRK2) are strongly associated with late-onset autosomal dominant Parkinson's disease. We employed a new, parallel, compound-centric approach to identify a potent and selective LRRK2 inhibitor, LRRK2-IN-1, and demonstrated that inhibition of LRRK2 induces dephosphorylation of Ser910 and Ser935 and accumulation of… (More)
DOI: 10.1038/nchembio.538


3 Figures and Tables